Members – make sure you are vaccinated for measles
The College is supporting a call from the Academy of Medical Royal Colleges encouraging members to ensure they are vaccinated for measles.
Being up to date with vaccines is an important component of what doctors need to do to protect ourselves and our patients, the Academy said this month.
About the measles vaccine
The measles vaccine was introduced in the UK in 1968 but uptake was low until it changed to the MMR vaccine in 1988.
In November 1994, a large campaign with measles-rubella vaccine was offered to everyone at school (those aged 5-16 years), and a second dose of MMR was then introduced at pre-school age in 1996. Other countries introduced measles and MMR vaccines at different times.
Do I need to have the MMR vaccination?
The national recommendation for all healthcare staff is that they should be up to date with their routine immunisations – the MMR vaccine is particularly important to reduce transmission and to protect you and your patients.
Satisfactory evidence of protection include documentation of two doses of MMR vaccine or a positive antibody test for both measles and rubella. This should be available in your occupational health department.
Anyone born in the UK before 1970 is likely to have had measles as a child.
You can check whether you had your childhood vaccines with your GP, and if not, you can receive MMR vaccination on the NHS. This will protect you, and those around you, both at work and in the community.
If you are not sure, you can still have MMR vaccination on the NHS. The rate of side effects is lower with second (and subsequent) doses and so it is not harmful to have an extra dose.
If you look after patients with immunosuppression
Clinicians who look after individuals with immunosuppression should ideally ensure their patients are up to date with vaccinations prior to starting immunosuppressive therapy - you should also advise the same for their friends and family.
If timing does not allow not, consider testing individuals for measles IgG (see Annex 2 in the national measles guidelines). This will help guide their management when measles is circulating in the community.